Document is current

Any future updates will be listed below

CML Therapy: A Focus on Second- and Third-Generation Tyrosine Kinase Inhibitors

Crossref DOI link: https://doi.org/10.1007/978-3-030-71913-5_5

Published Online: 2021-06-03

Published Print: 2021

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark